We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with neurological disorders.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved eplontersen (Wainzua) to treat adults with polyneuropathy associated with hereditary transthyretin amyloidosis (ATTRv), which is a rare progressive condition that runs in families caused by a protein called transthyretin (TTR).
Projects granted during 2015 that have a primary purpose of translational and applied research: human nervous system and mental disorders.
Signs that may suggest rabies in bats, what to do if you spot them and measures to prevent exposing yourself to the disease.
Information on nerve agents, for use in responding to chemical incidents.
Information and advice on rabies, the viral infection of the central nervous system which affects mammals and humans.
Projects granted during 2015 with a primary purpose of basic research: nervous system.
Guillain-Barré syndrome is a rare neurological condition which can occur following Zika virus infection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).